Calidi Biotherapeutics (CLDI) Institutional Ownership $0.49 +0.01 (+1.55%) As of 01:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Calidi Biotherapeutics (NYSE:CLDI)CurrentInstitutional OwnershipPercentage12.53%Number ofInstitutional Buyers(last 12 months)13TotalInstitutional Inflows(last 12 months)$661.29KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$659.08K Get CLDI Insider Trade Alerts Want to know when executives and insiders are buying or selling Calidi Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CLDI Institutional Buying and Selling by Quarter Calidi Biotherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Millennium Management LLC136,137$157K0.0%+35.5%0.515% 2/14/2025Jane Street Group LLC33,437$38K0.0%N/A0.126% 2/12/2025Geode Capital Management LLC160,018$184K0.0%+304.0%0.605% 2/11/2025Virtu Financial LLC73,448$84K0.0%N/A0.278% 2/10/2025 RS Crum Inc.40,463$47K0.0%N/A0.153% 2/7/2025HighTower Advisors LLC102,276$118K0.0%N/A0.386% 2/3/2025Red Wave Investments LLC80,828$93K0.0%+74.0%0.305% 1/22/2025Drive Wealth Management LLC90,000$104K0.0%N/A0.340% 1/14/2025 CPR Investments Inc.101,000$116K0.1%+80.4%0.772% 11/15/2024Red Wave Investments LLC46,461$53K0.0%-92.6%0.418% 8/15/2024Delta Investment Management LLC210,230$42K0.0%+1,955.0%0.413% 8/8/2024 RS Crum Inc.263,470$53K0.0%+2,327.4%0.517% 7/19/2024 CPR Investments Inc.560,000$112K0.1%+700.0%11.002% 5/16/2024Apollo Management Holdings L.P.125,000$71K0.0%N/A0.352% 5/15/2024Magnetar Financial LLC63,132$36K0.0%N/A0.178% 5/14/2024Evermay Wealth Management LLC63,416$36K0.0%N/A0.178% 4/23/2024 Spectrum Asset Management Inc. NB CA 166,494$94K0.0%N/A0.468% (Data available from 1/1/2016 forward) CLDI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CLDI shares? During the previous two years, 14 institutional investors and hedge funds held shares of Calidi Biotherapeutics. The most heavily invested institutionals were Geode Capital Management LLC ($184K), Millennium Management LLC ($157K), HighTower Advisors LLC ($118K), CPR Investments Inc. ($116K), Drive Wealth Management LLC ($104K), Spectrum Asset Management Inc. NB CA ($94K), and Red Wave Investments LLC ($93K).Learn more on CLDI's institutional investors. What percentage of Calidi Biotherapeutics stock is owned by institutional investors? 12.53% of Calidi Biotherapeutics stock is owned by institutional investors. Learn more on CLDI's institutional investor holdings. Which institutional investors have been buying Calidi Biotherapeutics stock? Of the 14 institutional investors that purchased Calidi Biotherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: CPR Investments Inc. ($535K), RS Crum Inc. ($293.08K), Delta Investment Management LLC ($200K), Spectrum Asset Management Inc. NB CA ($166.49K), Apollo Management Holdings L.P. ($125K), Geode Capital Management LLC ($120.41K), and HighTower Advisors LLC ($102.28K). How much institutional buying is happening at Calidi Biotherapeutics? Institutional investors have bought a total of 1,935,692 shares in the last 24 months. This purchase volume represents approximately $661.29K in transactions. Which Calidi Biotherapeutics major shareholders have been selling company stock? The following institutional investors have sold Calidi Biotherapeutics stock in the last 24 months: Red Wave Investments LLC ($578.14K). How much institutional selling is happening at Calidi Biotherapeutics? Institutional investors have sold a total of 578,141 shares in the last 24 months. This volume of shares sold represents approximately $659.08K in transactions. Related Companies Oncolytics Biotech Institutional Ownership PepGen Institutional Ownership Immuneering Institutional Ownership PDS Biotechnology Institutional Ownership Skye Bioscience Institutional Ownership Gain Therapeutics Institutional Ownership ImmuCell Institutional Ownership Cue Biopharma Institutional Ownership VolitionRx Institutional Ownership Outlook Therapeutics Institutional Ownership This page (NYSE:CLDI) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calidi Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Calidi Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
